Dr Stylianos Arseniou

Background

Dr Stylianos Arseniou is a neurologist and consultant in clinical neurophysiology at Chelsea and Westminster Hospital. Dr Arseniou graduated at the University of Padova in Italy and pursued his neurology training in Athens and at the University Hospital of Larissa in Greece. In 2017 he moved to the UK, when he joined the GMC Specialist Register for neurology and completed his Clinical Neurophysiology Fellowship at the National Hospital for Neurology and Neurosurgery in 2021.

In parallel, he completed his PhD in neurology at the University of Thessaly in Greece and a fellowship in EEG and epilepsy at the Cleveland University Hospital in USA, where he further developed his special interest in EEG of the brain cortex.

Since 2021 he has been a consultant in clinical neurophysiology and he runs the nerve conduction studies/Electromyography (NCS/EMG) and electroencephalography (EEG) clinics. His research has been mainly focused on the peripheral nerve disorders and neurophysiology.

Expertise

Nerve Conduction Studies (NCS) and Electromyography (EMG). Electrophysiological evaluation and investigation of various nervous system disorders, such as all kind of peripheral neuropathies: inflammatory, congenital, focal entrapment neuropathies (i.e. Carpal Tunnel Syndrome-CTS), radiculopathies, myopathies, motor neuron diseases, neuromuscular junction disorders. Electroencephalography (EEG): to support the diagnosis of epilepsy and dementia syndromes. Basic and advanced reporting of routine and sleep deprived EEGs, as well as monitoring and ambulatory (24h) EEGs. Evoked Potentials (EPs).

Research & publications

SLC2A3 rs12842 polymorphism and risk of Alzheimer’s disease. Arseniou S, Siokas V, Aloizou AM, Stamati P, Mentis AA, Tsouris Z, Dastamani M, Peristeri E, Valotassiou , Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. Neurol Res, 2020, 42:853-861

Does the rs3865444 polymorphism confer susceptibility to Alzheimer’s disease? Siokas V, Aslanidou P, Aloizou AM, Peristeri E, Stamati P, Liampas I, Arseniou S, Drakoulis N, Aschner M, Tsatsakis A, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. J Mol Neurosci, 2020, 70:851-860

Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk? Stamati P, Siokas V, Aloizou AM, Karampinis E, Arseniou S, Rakitskii VN, Tsatsakis A, Spandidos DA, Gozes I, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. J Mol Neurosci, 2019, 69:343-350

Vitamin B12, folate, and homocysteine levels and multiple sclerosis: A meta-analysis. Dardiotis E, Arseniou S, Sokratous M, Tsouris Z, Siokas V, Mentis AA, Michalopoulou A, Andravizou A, Dastamani M, Paterakis K, Bogdanos D, Brotis A. Mult Scler Relat Disord. 2017, 17:190-197

There is no safe threshold for lead exposure: a literature review. T.Vorvolakos, S.Arseniou, M.Samakouri. Psychiatriki, 2016, 27:204-214

Deciphering the role of DNA methylation in multiple sclerosis: emerging issues. Sokratous M, Dardiotis E, Tsouris Z, Bellou E, Michalopoulou A, Siokas V, Arseniou S, Stamati T, Tsivgoulis G, Bogdanos D, Hadjigeorgiou GM. Auto Immun Highlights 2016, 7(1):12

HIV infection and depression. Arseniou S, Arvaniti A, Samakouti M. Psychiatry Clin Neurosci. 2014, 68(2): 96-109

Post-stroke depression: recognition and treatment interventions. Arseniou S, Arvaniti A, Samakouti M. Psychiatriki, 2011, 22(3):240-8

1) EEG Epilepsy Intensive Course, 240 Hours, Cleveland-USA, 04/02-31/03/2019
2) Basic principles of Neuromuscular Ultrasound Imaging-Clinical Neurophysiology Department-Kent and Canterbury Hospital,10-19/12/2018
3) Licensed Acupuncture Physician, after successful examination, by the Greek Medical Association of Acupuncture, 2013-2014

• Member of the research team in the neurogenetics department-University of Thessaly, where he participates in neurogenetics studies, as well as in the IGOS study (International GBS Outcome Study).